Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-04T18:14:32.624Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of OBRA regulations in the USA

Published online by Cambridge University Press:  17 November 2008

David A Smith
David A Smith
Affiliation:
Professor, Family Medicine/Psychiatry, University of South Dakota School of Medicine, Dakota Human Services Center, Yankton Office, 1000 West 4th Street #3, Yankton, SD 57078-3718, USA.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Reviews in Clinical Gerontology , Volume 3 , Issue 1 , February 1993 , pp. 1 - 2
Copyright
Copyright © Cambridge University Press 1993

References

1Health Care Financing Administration. State operations manual. Maryland: US Department of Health and Human Services; 1989. Transmitted 232.Google Scholar
2Garrard, J, Makris, L, Dunham, T et al. , Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. JAMA 1991; 265: 463.CrossRefGoogle ScholarPubMed
3Zimmer, JG, Watson, N, Treat, A.Behavioral problems among patients in skilled nursing home facilities. AJPH. 1984; 74: 1118.CrossRefGoogle Scholar
4Chandler, JD, Chandler, JE.The prevalence of neuropsychiatric disorders in a nursing home population. J Geriatr Psychiatry Neurol 1988; 1: 71.CrossRefGoogle Scholar
5Morriss, RK, Rovner, BW, Folstein, M, German, PS. Delusions in newly admitted residents of nursing homes. Am J Psychiatry 1990; 147: 299.Google ScholarPubMed
6Smith, DA.The family practitioner and psychiatric problems in the old. JAMA 1987; 257: 2288.CrossRefGoogle ScholarPubMed
7Beers, M, Avorn, J, Soumeral, SD et al. , Psychoactive medication use in intermediate-care facility residents. JAMA 1988; 260: 3016.CrossRefGoogle ScholarPubMed
8Ray, WA, Federspiel, CF, Schaffner, W.A study of antipsychotic drug use in nursing homes: epidemiologic evidence of misuse. Am J Public Health 1980; 70: 485.CrossRefGoogle ScholarPubMed
9Ray, WA, Griffin, MR, Schaffner, W et al. , Psychotropic drug use and the risk of hip fracture. N EnglJ Med 1987; 316: 363.CrossRefGoogle ScholarPubMed
10Schneider, LS, Pollock, VE, Lyness, SA.A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatric Soc 1990; 38: 553.CrossRefGoogle ScholarPubMed
11Tinetti, M, Liu, W, Marottoli, R, Ginter, S.Mechanical restraint use among residents of skilled nursing facilities; prevalence, patterns and predictors. JAMA 1991; 265: 468.CrossRefGoogle Scholar
12Meltzer, HY ed. Psychopharmacology: the third generation of progress. Raven Press, New York, 1987.Google Scholar
13Smith, DA. Nursing home rights and physical restraints. J Med Direction; 01 1992: 9.Google Scholar
14Nursing homes report decreased restraint use. AGS Newsletter 1992; 21: 1.Google Scholar